Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
Brod Group
h-index: 32
Total citations: 5,145
Total papers: 144
Homepage:
http://www.thebrodgroup.net/
Recent papers from Brod Group
Steroid-Refractory Idiopathic Hypereosinophilic Syndrome with Prolonged Respiratory Failure Responsive to Mepolizumab
SHILAP Revista de lepidopterología · 2026
Patient-reported experiences of cognitive difficulties and their impact on daily life in narcolepsy type 1
Frontiers in Neurology · 2026
Patient-Reported Outcomes in Palopegteriparatide-Treated Adults with Hypoparathyroidism: PaTH Forward Trial Extension
The Journal of Clinical Endocrinology & Metabolism · 2025
Development and validation of an eating behavior patient‐reported outcome measure in people living with obesity or overweight
Obesity · 2025
Developing a Process for Preference Measures in Pediatric Growth Hormone Deficiency: Challenges and Solutions
Patient Preference and Adherence · 2025
Development and validation of the Child Hemophilia Treatment Experience Measure: A new observer‐reported outcome measure
Haemophilia · 2024
Measuring treatment impacts on symptoms in adults with hypoparathyroidism: findings from the PaTHway trial
Journal of Patient-Reported Outcomes · 2024
Scholarly Productivity of US Medical Schools Before and During the COVID-19 Pandemic
Southern Medical Journal · 2023
Weekly Somapacitan in GH Deficiency: 4-Year Efficacy, Safety, and Treatment/Disease Burden Results From REAL 3
The Journal of Clinical Endocrinology & Metabolism · 2023
Understanding treatment burden in hemophilia: development and validation of the Hemophilia Treatment Experience Measure (Hemo-TEM)
Journal of Patient-Reported Outcomes · 2023
Psychometric Validation of the Growth Hormone Deficiency–Child Treatment Burden Measure (GHD-CTB) and the Growth Hormone Deficiency–Parent Treatment Burden Measure (GHD-PTB)
PharmacoEconomics - Open · 2022
Improving adherence to guidelines for spine pain care: what tools could support primary care clinicians in conforming to guidelines?
BMJ Open Quality · 2022
Effective GH Replacement With Once-weekly Somapacitan vs Daily GH in Children with GHD: 3-year Results From REAL 3
The Journal of Clinical Endocrinology & Metabolism · 2021
Functioning and well‐being in older children and adolescents with achondroplasia: A qualitative study
American Journal of Medical Genetics Part A · 2021
Psychometric validation of the Hypoparathyroidism Patient Experience Scales (HPES)
Journal of Patient-Reported Outcomes · 2021
A qualitative study of the impacts of having an infant or young child with achondroplasia on parent well-being
Orphanet Journal of Rare Diseases · 2021
PaTH Forward: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult Hypoparathyroidism
The Journal of Clinical Endocrinology & Metabolism · 2021
Psychometric Validation of the Growth Hormone Deficiency-Child Impact Measure (GHD-CIM)
PharmacoEconomics - Open · 2021
Assessing physical symptoms, daily functioning, and well‐being in children with achondroplasia
American Journal of Medical Genetics Part A · 2020
Living with hypoparathyroidism: development of the Hypoparathyroidism Patient Experience Scale-Impact (HPES-Impact)
Quality of Life Research · 2020